Assessment of Gentamicin and Ertapenem Susceptibilities of Canadian Neisseria Gonorrhoeae Isolates
Pam Sawatzky, BSc1, Irene Martin, BSc1, Angela Yuen, Student1, Vanessa Allen, MD2, Linda Hoang, MD3, Brigitte Lefebvre, PhD4, Marguerite Lovgren, BSC5, Greg Horsman, MD6, Paul Vancaeseele, MD7, Richard Garceau, MD8, Tom Wong, MD, MPH, FRCPC9, Chris Archibald, MDCM, MHSc, FRCPC10 and Michael Mulvey, PHD11, 1Streptococcus and STI Unit, National Microbiology Laboratory, Winnipeg, MB, Canada, 2Public Health Ontario, Canada, 3British Columbia Centre for Disease Control, Canada, 4Laboratoire de santé publique du Québec, Canada, 5Alberta Provincial Laboratory for Public Health, Canada, 6Saskatchewan Disease Control Laboratory, Canada, 7Cadham Provincial Laboratory, Canada, 8George L Dumont Hospital, Canada, 9Professional Guidelines and Public Health Practice Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON, Canada, 10Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON, Canada, 11National Microbiology Laboratory, Canada